Prohance and Prostatic disorder - a phase IV clinical study of FDA data
Summary:
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Prohance?
Prohance has active ingredients of gadoteridol. Currently, eHealthMe is studying from 3,684 Prohance users.
What is Prostatic Disorder?
Prostatic disorder is found to be associated with 938 drugs and 418 conditions by eHealthMe. Currently, we are studying 13,907 people who have Prostatic disorder.
Do you take Prohance and have Prostatic disorder?
Check whether Prostatic disorder is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Prohance side effects by duration, gender and age:
- Prohance side effects (3,684 reports)
Prostatic disorder treatments and more:
- Prostatic disorder (13,907 reports)
All the drugs that are associated with Prostatic disorder:
All the conditions that are associated with Prostatic disorder:
How the study uses the data?
The study uses data from the FDA. It is based on gadoteridol (the active ingredients of Prohance) and Prohance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fosphenytoin Sodium and Death - 5 seconds ago
- Ivermectin and Overdose - 5 seconds ago
- Indocin and Coronary Artery Bypass - 5 seconds ago
- Starlix and Hallucinations - 9 seconds ago
- Solifenacin Succinate and Celebrex drug interaction - 11 seconds ago
- Alphagan P and Kidney Stones - 13 seconds ago
- Symmetrel and Cardiac Failure Congestive - 17 seconds ago
- Akynzeo and Chest Pain - 18 seconds ago
- Vincristine Sulfate and Abdominal Mass - 20 seconds ago
- Tegretol and Gablofen drug interaction - 22 seconds ago